```html

Pulmonitis (Bronchitis) – Comprehensive Medical Guide

Overview

Pulmonitis is the medical term for inflammation of the bronchial tubes, the airways that carry air to and from the lungs. In everyday language the condition is most often called bronchitis.

• Acute bronchitis develops suddenly, usually after a viral upper‑respiratory infection and lasts a few days to three weeks.
• Chronic bronchitis is defined by a cough that produces sputum for at least three months in two consecutive years; it is a major component of chronic obstructive pulmonary disease (COPD).

Bronchitis can affect anyone, but the risk profile differs between the acute and chronic forms.

Who it affects

• Acute bronchitis: most common in children and adults during the fall and winter respiratory virus season. Approximately 5–10 % of all outpatient visits for a cough are diagnosed as acute bronchitis.<sup>1</sup>
• Chronic bronchitis: predominately adults over 40 years old, especially smokers. In the United States, an estimated 6.5 % of adults have chronic bronchitis, representing about 14 million people.<sup>2</sup>

Prevalence worldwide

The World Health Organization (WHO) reports that COPD – of which chronic bronchitis is a key phenotype – affected 251 million people worldwide in 2022, causing 3.23 million deaths.<sup>3</sup> Acute bronchitis episodes are far more common but are usually self‑limited and rarely reported in national statistics.

Symptoms

Symptoms can vary markedly between acute and chronic forms. Below is a complete list with short descriptions.

Acute bronchitis

• Persistent cough – often the first symptom; may be dry or produce clear, yellow, or green sputum.
• Sore throat – irritation from post‑nasal drip.
• Low‑grade fever – typically < 38.5 °C (101.3 °F).
• Chest discomfort – a feeling of tightness or mild pain that worsens with coughing.
• Fatigue and malaise – general tiredness.
• Wheezing – a whistling sound during breathing, especially on exhalation.
• Shortness of breath – usually mild; improves with rest.

Chronic bronchitis

• Chronic productive cough – sputum production for ≥3 months/yr for ≥2 years.
• Dyspnea on exertion – shortness of breath during walking, climbing stairs, or other activities.
• Frequent respiratory infections – recurrent colds, flu‑like illnesses, or pneumonia.
• Wheezing and crackles – heard on auscultation.
• Bluish discoloration of lips or fingertips (cyanosis) – indicates low oxygen levels.
• Weight loss and muscle wasting – in advanced disease.

Causes and Risk Factors

Bronchitis is essentially an inflammatory response of the bronchial lining. The underlying triggers differ between the acute and chronic types.

Acute bronchitis

• Viral infections – the most common cause (≈80 %). Influenza, respiratory syncytial virus (RSV), rhinovirus, adenovirus, and coronavirus (including SARS‑CoV‑2) are frequent culprits.<sup>4</sup>
• Bacterial superinfection – less common (≈5–10 %); typical organisms include Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
• Irritants – exposure to tobacco smoke, air pollution, occupational dust, or chemicals can provoke inflammation.

Chronic bronchitis

• Smoking – the single greatest risk factor; up to 90 % of chronic bronchitis patients are current or former smokers.<sup>5</sup>
• Second‑hand smoke – increases risk, especially in children and nonsmoking adults.
• Occupational exposure – coal dust, silica, asbestos, organic dusts, and certain chemical fumes.
• Air pollution – long‑term exposure to fine particulate matter (PM2.5) is linked to higher prevalence.
• Genetic susceptibility – alpha‑1 antitrypsin deficiency can predispose to early‑onset chronic bronchitis.
• Age & gender – prevalence rises after age 40; historically higher in men, though the gap is closing as smoking patterns change.

Diagnosis

Accurate diagnosis distinguishes bronchitis from pneumonia, asthma, heart failure, or lung cancer, which may present with similar symptoms.

Clinical evaluation

• History – duration of cough, sputum characteristics, exposure to smoke or pollutants, recent infections, and comorbidities.
• Physical examination – auscultation for wheezes, rhonchi, or crackles; assessment of respiratory rate and oxygen saturation.

Diagnostic tests

1. Chest X‑ray – routinely performed to exclude pneumonia or lung masses. In uncomplicated acute bronchitis the X‑ray is usually normal.
2. Pulmonary function tests (PFTs) – spirometry measures FEV₁/FVC ratio; useful for confirming COPD in chronic bronchitis.
3. Sputum analysis – Gram stain and culture if bacterial infection is suspected (e.g., persistent high‑grade fever, purulent sputum).
4. Blood tests – CBC may show mild leukocytosis; C‑reactive protein (CRP) or procalcitonin can help differentiate bacterial from viral causes.
5. Pulse oximetry – assesses oxygen saturation; values < 92 % at rest may indicate the need for supplemental oxygen.

Treatment Options

Treatment is tailored to the type (acute vs. chronic) and severity.

Acute bronchitis

• Supportive care – rest, adequate hydration, and humidified air. Over‑the‑counter (OTC) analgesics such as acetaminophen or ibuprofen relieve fever and aches.
• Cough suppressants – dextromethorphan may be used for a disruptive dry cough; expectorants like guaifenesin help thin mucus.
• Bronchodilators – short‑acting beta‑agonists (e.g., albuterol) can relieve wheezing, especially in patients with underlying asthma.
• Antibiotics – generally NOT indicated for viral bronchitis. They are reserved for confirmed bacterial infection, COPD exacerbation, or high‑risk patients (e.g., immunocompromised). Common choices: amoxicillin‑clavulanate, macrolides, or doxycycline.
• Antiviral therapy – may be considered if influenza is confirmed and the patient presents within 48 hours of symptom onset (e.g., oseltamivir).

Chronic bronchitis (COPD component)

1. Smoking cessation – the most effective intervention; nicotine‑replacement therapy, varenicline, or bupropion improve quit rates.
2. Bronchodilators
   • Short‑acting (SABA) for relief of acute dyspnea.
   • Long‑acting beta‑agonists (LABA) and/or long‑acting muscarinic antagonists (LAMA) for maintenance therapy.
3. Inhaled corticosteroids (ICS) – added for patients with ≥2 exacerbations per year or eosinophilic inflammation.
4. Phosphodiesterase‑4 inhibitor (roflumilast) – for severe COPD with chronic bronchitis phenotype.
5. Pulmonary rehabilitation – supervised exercise, breathing techniques, and education improve quality of life.
6. Vaccinations – annual influenza vaccine and 23‑valent pneumococcal vaccine reduce infection risk.
7. Oxygen therapy – indicated when resting PaO₂ ≤55 mm Hg or SpO₂ ≤88 %.
8. Antibiotics – used for acute exacerbations with increased sputum purulence, volume, or dyspnea; common regimens include amoxicillin‑clavulanate, macrolides, or quinolones.
9. Surgical options – rare; lung volume reduction surgery or lung transplantation may be considered in end‑stage disease.

Living with Pulmonitis (bronchitis)

Self‑management is key to minimizing symptoms and preventing exacerbations.

Daily management tips

• Stay hydrated – 8‑10 glasses of water per day thin mucus.
• Use a humidifier – especially in dry climates; keep it clean to prevent mold.
• Practice paced breathing – pursed‑lip breathing reduces airway collapse during exhalation.
• Avoid triggers – smoke, strong fragrances, dust, and cold air.
• Medication adherence – use inhalers correctly; clean spacer devices daily.
• Regular physical activity – low‑impact aerobic exercise (walking, cycling) improves lung capacity.
• Weight management – maintain a healthy BMI; excess weight worsens dyspnea.
• Monitor symptoms – keep a diary of cough frequency, sputum color, and breathlessness to identify early exacerbations.
• Plan for emergencies – have a rescue inhaler and a written action plan from your provider.

Prevention

Many preventive measures target the underlying risk factors.

1. Quit smoking – the single most effective strategy; seek counseling, nicotine replacement, or prescription aids.
2. Vaccinate – flu shot every fall; pneumococcal vaccine per CDC guidelines (PCV20 or PCV15 + PPSV23 for adults ≥65 y or at high risk).
3. Hand hygiene – wash hands >20 seconds or use alcohol‑based sanitizer during cold‑and‑flu season.
4. Avoid crowded indoor spaces during viral outbreaks.
5. Use protective equipment – masks, respirators, or ventilation in workplaces with dust, chemicals, or fumes.
6. Maintain indoor air quality – air filters (HEPA), regular HVAC cleaning, and reducing indoor smoking.
7. Regular health check‑ups – spirometry for at‑risk adults, especially smokers over 40.

Complications

If untreated or poorly managed, bronchitis can lead to serious health problems.

• Pneumonia – infection spreads to the lung parenchyma.
• Chronic obstructive pulmonary disease (COPD) progression – irreversible airflow limitation.
• Respiratory failure – inadequate gas exchange may require mechanical ventilation.
• Cor pulmonale – right‑heart strain due to chronic low oxygen levels.
• Frequent exacerbations – each episode accelerates lung function decline.
• Bronchiectasis – permanent dilation of bronchi from repeated inflammation.

When to Seek Emergency Care

---

References

1. Mayo Clinic. Acute bronchitis. https://www.mayoclinic.org.
2. CDC. Chronic Obstructive Pulmonary Disease (COPD) Surveillance—United States. 2023. https://www.cdc.gov.
3. World Health Organization. COPD factsheet. 2022. https://www.who.int.
4. National Institutes of Health, National Library of Medicine. Bronchitis. MedlinePlus. https://medlineplus.gov.
5. American Lung Association. Smoking and COPD. 2024. https://www.lung.org.

```